These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 37919739)
1. FTO facilitates cancer metastasis by modifying the m Gao L; Wang A; Chen Y; Cai X; Li Y; Zhao J; Zhang Y; Zhang W; Zhu J; Zeng Y; Liu Z; Huang JA Cell Commun Signal; 2023 Nov; 21(1):311. PubMed ID: 37919739 [TBL] [Abstract][Full Text] [Related]
2. Phenethyl isothiocyanate inhibits metastasis potential of non-small cell lung cancer cells through FTO mediated TLE1 m Zhang QC; Qian YM; Ren YH; Chen MM; Cao LM; Zheng SJ; Li BB; Wang M; Wu X; Xu K Acta Pharmacol Sin; 2024 Mar; 45(3):619-632. PubMed ID: 37848553 [TBL] [Abstract][Full Text] [Related]
3. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner. Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515 [TBL] [Abstract][Full Text] [Related]
4. LncRNA GAS5 regulated by FTO-mediated m6A demethylation promotes autophagic cell death in NSCLC by targeting UPF1/BRD4 axis. Fu Y; Liu L; Wu H; Zheng Y; Zhan H; Li L Mol Cell Biochem; 2024 Mar; 479(3):553-566. PubMed ID: 37120495 [TBL] [Abstract][Full Text] [Related]
5. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2. Wang F; Hu Y; Wang H; Hu P; Xiong H; Zeng Z; Han S; Wang D; Wang J; Zhao Y; Huang Y; Zhuo W; Lv G; Zhao G J Exp Clin Cancer Res; 2023 Oct; 42(1):267. PubMed ID: 37840133 [TBL] [Abstract][Full Text] [Related]
6. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3. Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314 [TBL] [Abstract][Full Text] [Related]
7. RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma. Cui Y; Zhang C; Ma S; Li Z; Wang W; Li Y; Ma Y; Fang J; Wang Y; Cao W; Guan F J Exp Clin Cancer Res; 2021 Sep; 40(1):294. PubMed ID: 34544449 [TBL] [Abstract][Full Text] [Related]
8. RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an m Tan Z; Shi S; Xu J; Liu X; Lei Y; Zhang B; Hua J; Meng Q; Wang W; Yu X; Liang C Oncogene; 2022 May; 41(20):2860-2872. PubMed ID: 35422475 [TBL] [Abstract][Full Text] [Related]
9. FTO up-regulation induced by MYC suppresses tumour progression in Epstein-Barr virus-associated gastric cancer. Xu YY; Li T; Shen A; Bao XQ; Lin JF; Guo LZ; Meng Q; Ruan DY; Zhang QH; Zuo ZX; Zeng ZL Clin Transl Med; 2023 Dec; 13(12):e1505. PubMed ID: 38082402 [TBL] [Abstract][Full Text] [Related]
10. The FTO/miR-181b-3p/ARL5B signaling pathway regulates cell migration and invasion in breast cancer. Xu Y; Ye S; Zhang N; Zheng S; Liu H; Zhou K; Wang L; Cao Y; Sun P; Wang T Cancer Commun (Lond); 2020 Oct; 40(10):484-500. PubMed ID: 32805088 [TBL] [Abstract][Full Text] [Related]
11. The antagonistic effect of FTO on METTL14 promotes AKT3 m Wei R; Zhao F; Kong L; Pu Y; Li Y; Zang C J Cancer Res Clin Oncol; 2024 Mar; 150(3):131. PubMed ID: 38491196 [TBL] [Abstract][Full Text] [Related]
12. FTO/IGF2BP2-mediated N6 methyladenosine modification in invasion and metastasis of thyroid carcinoma via CDH12. Chen Z; Zhong X; Xia M; Liu C; Tang W; Liu G; Yi Y; Guo Y; Jiang Q; Zu X; Zhong J Cell Death Dis; 2024 Oct; 15(10):733. PubMed ID: 39379360 [TBL] [Abstract][Full Text] [Related]
13. FTO-mediated autophagy promotes progression of clear cell renal cell carcinoma via regulating SIK2 mRNA stability. Xu Y; Zhou J; Li L; Yang W; Zhang Z; Zhang K; Ma K; Xie H; Zhang Z; Cai L; Gong Y; Gong K Int J Biol Sci; 2022; 18(15):5943-5962. PubMed ID: 36263177 [TBL] [Abstract][Full Text] [Related]
14. FTO blocks RNA translational activity via the loss of N6-methyladenosine methylation at 5' UTR regulated by RBM5 in cisplatin-resistant NSCLC. Li L; Qu D; Wang B; Yuan S; Zhao Y; Liu N; Huo F; Zhang D; Zhang L J Cell Physiol; 2024 Aug; 239(8):e31296. PubMed ID: 38742685 [TBL] [Abstract][Full Text] [Related]
15. FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway. Zhang L; Wan Y; Zhang Z; Jiang Y; Lang J; Cheng W; Zhu L RNA Biol; 2021 Sep; 18(9):1265-1278. PubMed ID: 33103587 [TBL] [Abstract][Full Text] [Related]
16. N6-methyladenosine demethylase fat mass and obesity-associated protein suppresses hyperglycemia-induced endothelial cell injury by inhibiting reactive oxygen species formation via autophagy promotion. Xie D; Yang K; Xu Y; Li Y; Liu C; Dong Y; Chi J; Yin X J Diabetes Complications; 2024 Aug; 38(8):108801. PubMed ID: 38935979 [TBL] [Abstract][Full Text] [Related]
17. FTO mediated ERBB2 demethylation promotes tumor progression in esophageal squamous cell carcinoma cells. Zhao F; Ge F; Xie M; Li Z; Zang C; Kong L; Pu Y; Zheng X; Tan Y Clin Exp Metastasis; 2022 Aug; 39(4):623-639. PubMed ID: 35524932 [TBL] [Abstract][Full Text] [Related]
18. circNOX4 activates an inflammatory fibroblast niche to promote tumor growth and metastasis in NSCLC via FAP/IL-6 axis. Zhao Y; Jia Y; Wang J; Chen X; Han J; Zhen S; Yin S; Lv W; Yu F; Wang J; Xu F; Zhao X; Liu L Mol Cancer; 2024 Mar; 23(1):47. PubMed ID: 38459511 [TBL] [Abstract][Full Text] [Related]
19. m Liu J; Ren D; Du Z; Wang H; Zhang H; Jin Y Biochem Biophys Res Commun; 2018 Aug; 502(4):456-464. PubMed ID: 29842885 [TBL] [Abstract][Full Text] [Related]
20. CircGPR137B/miR-4739/FTO feedback loop suppresses tumorigenesis and metastasis of hepatocellular carcinoma. Liu L; Gu M; Ma J; Wang Y; Li M; Wang H; Yin X; Li X Mol Cancer; 2022 Jul; 21(1):149. PubMed ID: 35858900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]